Dividend Channel
Home BDCs Articles Declarations Calendar Calculator Screener ETFs Forums Contrarian Outlook
Free Dividend Report - Top Ranked Stocks

PARTNER NEWS:

Mon, Apr 8, 10:13 AM, Zacks
Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
Ocugen (OCGN) stock gains as the DSMB for the phase I/II study of OCU410 approves the initiation of dosing with the medium dose of OCU410 in the dose-escalation phase of the GA study.

Featured MNV Articles:

DGRO's Underlying Holdings Imply 11% Gain Potential
Friday, April 19, 7:25 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Analysts Predict 15% Gains Ahead For The Holdings of PSCI
Friday, April 19, 7:25 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

The Math Shows FTDS Can Go To $53
Friday, April 19, 7:25 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

VCR's Holdings Imply 16% Gain Potential
Friday, April 19, 7:25 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Peek Under The Hood: VIOV Has 20% Upside
Friday, April 19, 7:25 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

By Dividend Channel Staff, Wednesday, December 31, 7:00 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Dividend Channel | www.DividendChannel.com | Copyright © 2010 - 2024, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.